Large-Scale Study of Antibody Titer Decay following BNT162b2 mRNA Vaccine or SARS-CoV-2 Infection

Antibody persistence in the first six months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal study

(2021) Arnaud G. L’Huillier et al.   CLINICAL MICROBIOLOGY AND INFECTION

Evolution of antibody immunity to SARS-CoV-2

(2021) Christian Gaebler et al.   NATURE

Looking beyond COVID-19 vaccine phase 3 trials

(2021) Jerome H. Kim et al.   NATURE MEDICINE

SARS-CoV-2-directed antibodies persist for more than six months in a cohort with mild to moderate COVID-19

(2021) Vivian Glück et al.   INFECTION

Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7

(2021) Pengfei Wang et al.   NATURE

Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19

(2021) Adam K. Wheatley et al.   Nature Communications

Reactogenicity, safety and antibody response, after one and two doses of mRNA-1273 in seronegative and seropositive healthcare workers

(2021) Marie Tré-Hardy et al.   JOURNAL OF INFECTION

Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice

(2021) Raoul De Gasparo et al.   NATURE

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

(2021) David S. Khoury et al.   NATURE MEDICINE

Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2

(2021) Joseph E. Ebinger et al.   NATURE MEDICINE

SARS‐CoV‐2 antibodies started to decline just four months after COVID‐19 infection in a paediatric population

(2021) Adin Breuer et al.   ACTA PAEDIATRICA

In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies

(2021) Dapeng Li et al.   CELL

SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2

(2021) Fatima Amanat et al.   CELL

Antibody response to first and second dose of BNT162b2 in a cohort of characterized healthcare workers

(2021) Andrea Padoan et al.   CLINICA CHIMICA ACTA

SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses

(2021) Jackson S. Turner et al.   NATURE

Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection

(2021) Zijun Wang et al.   NATURE

Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants

(2021) Jianliang Xu et al.   NATURE

Present variants of concern and variants of interest of severe acute respiratory syndrome coronavirus 2: Their significant mutations in S‐glycoprotein, infectivity, re‐infectivity, immune escape and vaccines activity

(2021) Chiranjib Chakraborty et al.   REVIEWS IN MEDICAL VIROLOGY

Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants

(2021) Amarendra Pegu et al.   SCIENCE

Kinetics of SARS-CoV-2 anti-S IgG after BNT162b2 vaccination

(2021) Daniel Grupel et al.   VACCINE

One size does not fit all: Lessons from Israel's Covid-19 vaccination drive and hesitancy

(2021) Aviad Raz et al.   VACCINE

Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in Wuhan

(2021) Cesheng Li et al.   Nature Communications

Reduced antibody cross-reactivity following infection with B.1.1.7 than with parental SARS-CoV-2 strains

(2021) Nikhil Faulkner et al.   eLife

SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants

(2021) Daniel Martínez-Flores et al.   Frontiers in Immunology

Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination

(2021) Alice Cho et al.   NATURE

Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection: test negative design study

(2021) Ariel Israel et al.   BMJ-British Medical Journal

Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19

(2020) F. Javier Ibarrondo et al.   NEW ENGLAND JOURNAL OF MEDICINE

COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses

(2020) Ugur Sahin et al.   NATURE

Humoral Immune Response to SARS-CoV-2 in Iceland

(2020) Daniel F. Gudbjartsson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans

(2020) Jeffrey Seow et al.   Nature Microbiology

Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients

(2020) Anita S. Iyer et al.   Science Immunology

Correlates of protection against SARS-CoV-2 in rhesus macaques

(2020) Katherine McMahan et al.   NATURE

Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers

(2020) Sheila F. Lumley et al.   NEW ENGLAND JOURNAL OF MEDICINE

Exploiting Mucosal Immunity for Antiviral Vaccines

(2016) Akiko Iwasaki   Annual Review of Immunology